Autologous cancer vaccines
The invention relates to an autologous cancer vaccine and also to the method for producing same comprising the following steps: a) extracting the proteins contained in a serum or plasma sample obtained from a patient suffering from cancer; and b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or tricalcium phosphate.
1. A method for treating a patient suffering from a cancer, said method comprising the following steps:
a) extracting proteins contained in a serum or plasma sample obtained from a patient suffering from cancer;
b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or of tricalcium phosphate;
c) suspending, in an injection liquid, the particles of hydroxyapatite and/or of tricalcium phosphate brought into contact with the proteins in step b);
d) injecting the mixture obtained in step c) into the patient from whom the serum or plasma sample used in step a) was obtained.
2. The method as claimed in claim 1 , wherein the patient is a human.
3. The method as claimed in claim 1 , wherein the patient is a dog, a horse or a cat.
4. The method as claimed in claim 1 , wherein the cancer is chosen from melanomas, carcinomas, adenocarcinomas, sarcomas, central nervous system tumors, leukemias, lymphomas and cancers of infectious origin.
5. The method as claimed in claim 1 , wherein the cancer is chosen from the group consisting of osteosarcomas, B or T lymphomas, mammary tumors, melanomas, hemangio-sarcomas, mastocytomas, fibrosarcomas, brain or central nervous system tumors, schwannomas, mesotheliomas, seminomas, teratomas and blastomas.
6. The method as claimed in claim 1 , wherein the cancer is a glioblastoma, a sarcoma, a melanoma, a carcinoma or an adenocarcinoma.
7. The method as claimed in claim 1 , wherein the cancer is a cancer exhibiting metastases.